CRON Q3 2025 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q3 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$36M+6.1% YoY

Gross Profit

$18M50.4% margin

Operating Income

-$503,000-1.4% margin

Net Income

$26M71.4% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+8.6%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$46M

Stockholders' Equity

$1.1B

Cash & Equivalents

$784M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$34M	+6.1%
Gross Profit	$18M	$4M	+407.7%
Operating Income	-$503,000	-$34M	+98.5%
Net Income	$26M	$8M	+210.9%

Revenue Segments

Cannabis Flower

$26M73%

Cannabis Extracts

$10M27%

Product and Service, Other

$13,0000%

Geographic Segments

CANADA

$23M64%

ISRAEL

$11M31%

Other Countries

$2M5%